Labeler
Eisai Inc. NDC Codes
Eisai Inc. lists 28 finished drug products in the FDA NDC Directory under NDC labeler code 62856.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Active ingredients
- Perampanel, Lenvatinib, Rufinamide, Donepezil hydrochloride, Lecanemab-irmb, Lecanemab, Lemborexant, Eribulin mesylate
- NDC labeler codes
- 62856
- Strengths
- Lenvatinib 4 mg/1; Lecanemab-irmb 200 mg/mL; Lecanemab 100 mg/mL; Lenvatinib 10 mg/1; Lemborexant 5 mg/1; Lemborexant 10 mg/1; Perampanel .5 mg/mL; Perampanel 2 mg/1; Perampanel 4 mg/1; Perampanel 6 mg/1; Perampanel 8 mg/1; Perampanel 10 mg/1; Perampanel 12 mg/1; Rufinamide 40 mg/mL; Eribulin mesylate .5 mg/mL; Donepezil hydrochloride 23 mg/1; Rufinamide 200 mg/1; Rufinamide 400 mg/1; Donepezil hydrochloride 5 mg/1; Donepezil hydrochloride 10 mg/1
- Dosage forms
- Tablet, Film coated, Tablet, Capsule, Injection, Solution, Kit, Suspension, Injection
- Routes
- Oral, Intravenous, Subcutaneous
- Drug classes (FDA established)
- Noncompetitive AMPA Glutamate Receptor Antagonist, Kinase Inhibitor, Amyloid Beta-directed Antibody, Cholinesterase Inhibitor, Orexin Receptor Antagonist, Microtubule Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 41
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Lecanemab Autoinjectorlecanemab-irmb | Lecanemab-irmb 200 mg/mL | Injection, SolutionSubcutaneous | 62856-222 | 62856-0222-02 | — |
| Lecanemab Autoinjectorlecanemab-irmb | Lecanemab-irmb 200 mg/mL | Injection, SolutionSubcutaneous | 62856-220 | 62856-0220-01 | — |
| Leqembilecanemab | Lecanemab 100 mg/mL | Injection, SolutionIntravenous | 62856-212 | 62856-0212-01 | — |
| Leqembilecanemab | Lecanemab 100 mg/mL | Injection, SolutionIntravenous | 62856-215 | 62856-0215-01 | — |
| Dayvigolemborexant | Lemborexant 5 mg/1 | Tablet, Film coatedOral | 62856-405 | 62856-0405-1062856-0405-3062856-0405-90 | — |
| Dayvigolemborexant | Lemborexant 10 mg/1 | Tablet, Film coatedOral | 62856-410 | 62856-0410-3062856-0410-90 | — |
| Lenvimalenvatinib | Lenvatinib 4 mg/1 | CapsuleOral | 62856-704 | 62856-0704-30 | — |
| Lenvimalenvatinib | Lenvatinib 4 mg/1 | CapsuleOral | 62856-712 | 62856-0712-30 | — |
| Lenvimalenvatinib | Lenvatinib 4 mg/1 | CapsuleOral | 62856-708 | 62856-0708-30 | — |
| Lenvimalenvatinib | — | Kit | 62856-718 | 62856-0718-30 | — |
| Fycompaperampanel | Perampanel .5 mg/mL | SuspensionOral | 62856-290 | 62856-0290-38 | — |
| Lenvimalenvatinib | Lenvatinib 10 mg/1 | CapsuleOral | 62856-710 | 62856-0710-30 | — |
| Lenvimalenvatinib | — | Kit | 62856-714 | 62856-0714-30 | — |
| Lenvimalenvatinib | Lenvatinib 10 mg/1 | CapsuleOral | 62856-720 | 62856-0720-30 | — |
| Lenvimalenvatinib | — | Kit | 62856-724 | 62856-0724-30 | — |
| Fycompaperampanel | Perampanel 2 mg/1 | TabletOral | 62856-272 | 62856-0272-1462856-0272-3062856-0272-90 | — |
| Fycompaperampanel | Perampanel 4 mg/1 | TabletOral | 62856-274 | 62856-0274-1462856-0274-3062856-0274-90 | — |
| Fycompaperampanel | Perampanel 6 mg/1 | TabletOral | 62856-276 | 62856-0276-3062856-0276-90 | — |
| Fycompaperampanel | Perampanel 8 mg/1 | TabletOral | 62856-278 | 62856-0278-3062856-0278-90 | — |
| Fycompaperampanel | Perampanel 10 mg/1 | TabletOral | 62856-280 | 62856-0280-3062856-0280-90 | — |
| Fycompaperampanel | Perampanel 12 mg/1 | TabletOral | 62856-282 | 62856-0282-3062856-0282-90 | — |
| Banzelrufinamide | Rufinamide 40 mg/mL | SuspensionOral | 62856-584 | 62856-0584-46 | — |
| Halaveneribulin mesylate | Eribulin mesylate .5 mg/mL | InjectionIntravenous | 62856-389 | 62856-0389-01 | — |
| Ariceptdonepezil hydrochloride | Donepezil hydrochloride 23 mg/1 | Tablet, Film coatedOral | 62856-247 | 62856-0247-30 | — |
| Banzelrufinamide | Rufinamide 200 mg/1 | Tablet, Film coatedOral | 62856-582 | 62856-0582-0462856-0582-52 | — |
| Banzelrufinamide | Rufinamide 400 mg/1 | Tablet, Film coatedOral | 62856-583 | 62856-0583-1462856-0583-52 | — |
| Ariceptdonepezil hydrochloride | Donepezil hydrochloride 5 mg/1 | Tablet, Film coatedOral | 62856-245 | 62856-0245-30 | — |
| Ariceptdonepezil hydrochloride | Donepezil hydrochloride 10 mg/1 | Tablet, Film coatedOral | 62856-246 | 62856-0246-30 | — |
Eisai Inc.: common questions
- What is Eisai Inc.'s NDC labeler code?
- 62856. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Eisai Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.